Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,853 | 98 | 62.6% |
| Unspecified | $1,108 | 8 | 37.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,345 | 19 | $0 (2024) |
| Abbott Laboratories | $366.97 | 18 | $0 (2024) |
| Novo Nordisk Inc | $246.45 | 15 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $145.17 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $142.28 | 9 | $0 (2020) |
| Lilly USA, LLC | $104.66 | 7 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $100.16 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $82.24 | 5 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $58.62 | 4 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.66 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,197 | 13 | ABBVIE INC. ($1,108) |
| 2023 | $286.89 | 8 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($145.17) |
| 2022 | $129.64 | 6 | Abbott Laboratories ($92.28) |
| 2021 | $90.83 | 4 | AbbVie Inc. ($46.97) |
| 2020 | $151.78 | 8 | Genentech USA, Inc. ($24.48) |
| 2019 | $442.58 | 26 | Novo Nordisk Inc ($116.61) |
| 2018 | $350.13 | 22 | AbbVie, Inc. ($106.30) |
| 2017 | $312.51 | 19 | Janssen Pharmaceuticals, Inc ($65.37) |
All Payment Transactions
106 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | — | — | In-kind items and services | $375.96 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/15/2024 | ABBVIE INC. | — | — | In-kind items and services | $50.00 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/15/2024 | ABBVIE INC. | — | — | In-kind items and services | $50.00 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/15/2024 | ABBVIE INC. | — | — | In-kind items and services | $24.99 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/15/2024 | ABBVIE INC. | — | — | In-kind items and services | $22.63 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | ABBVIE INC. | — | — | In-kind items and services | $220.71 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/14/2024 | ABBVIE INC. | — | — | In-kind items and services | $142.90 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 11/13/2024 | ABBVIE INC. | — | — | In-kind items and services | $220.71 | Research |
| Study: A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ||||||
| 09/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: Diabetes Care | ||||||
| 06/04/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Diabetes Care | ||||||
| 05/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Diabetes Care | ||||||
| 03/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Diabetes Care | ||||||
| 12/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Diabetes Care | ||||||
| 12/14/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $145.17 | General |
| Category: Gastroenterology | ||||||
| 09/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes Care | ||||||
| 08/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Diabetes Care | ||||||
| 08/03/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: Diabetes Care | ||||||
| 06/04/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Diabetes Care | ||||||
| 04/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes Care | ||||||
| 01/06/2023 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Diabetes Care | ||||||
| 10/04/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Diabetes Care | ||||||
| 08/24/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diabetes Care | ||||||
| 07/15/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Diabetes Care | ||||||
| 06/08/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2a Multicenter, Randomized, Platform Study of Targeted Therapies for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease | ABBVIE INC. | $1,108 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 1 | 15 | 16 | $3,200 | $920.12 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 16 | $3,200 | $920.12 | 28.8% |
About George Silva
George Silva is a Family Medicine healthcare provider based in Mashpee, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1922000769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, George Silva has received a total of $2,961 in payments from pharmaceutical and medical device companies, with $1,197 received in 2024. These payments were reported across 106 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,853).
As a Medicare-enrolled provider, Silva has provided services to 15 Medicare beneficiaries, totaling 16 services with total Medicare billing of $920.12. Data is available for 1 year (2020–2020), covering 1 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mashpee, MA
- Active Since 08/11/2005
- Last Updated 10/04/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1922000769
Products in Payments
- FREESTYLE LIBRE 2 (Device) $221.30
- XIFAXAN (Drug) $145.17
- Synthroid (Drug) $129.74
- FREESTYLE LIBRE 3 (Device) $101.81
- Trintellix (Drug) $94.14
- JANUVIA (Drug) $88.98
- Ozempic (Drug) $69.84
- INVOKANA (Drug) $65.37
- Saxenda (Drug) $64.55
- FARXIGA (Drug) $62.84
- TRULICITY (Drug) $60.28
- UBRELVY (Drug) $59.94
- VRAYLAR (Drug) $47.56
- FreeStyle Libre 2 (Device) $43.86
- Xofluza (Drug) $43.42
- Livalo (Drug) $40.65
- SYMBICORT (Drug) $37.32
- Prolia (Biological) $35.38
- EMGALITY (Drug) $30.60
- VYVANSE (Drug) $30.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mashpee
Dr. Rocco Rossi, Do, DO
Family Medicine — Payments: $11,067
Haldor Barnes, M.d, M.D
Family Medicine — Payments: $6,891
Julia Craig-Muller, Md, MD
Family Medicine — Payments: $382.95
Dr. Mary-Amanda O'neill, M.d, M.D
Family Medicine — Payments: $173.30
Dr. Kristy Brown, D.o, D.O
Family Medicine — Payments: $172.28
Dr. Stephanie Prior, M.d, M.D
Family Medicine